SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001640334-24-000265
Filing Date
2024-02-16
Accepted
2024-02-16 06:01:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 lxrp_424b5.htm 424B5 349746
2 lxrp_424b5img4.jpg GRAPHIC 3961
3 lxrp_424b5img5.jpg GRAPHIC 3961
4 lxrp_424b5img6.jpg GRAPHIC 3961
  Complete submission text file 0001640334-24-000265.txt   367683
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B5 | Act: 33 | File No.: 333-262402 | Film No.: 24645683
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)